ADVIL MULTI-SYMPTOM COLD Drug Patent Profile
✉ Email this page to a colleague
When do Advil Multi-symptom Cold patents expire, and when can generic versions of Advil Multi-symptom Cold launch?
Advil Multi-symptom Cold is a drug marketed by Haleon Us Holdings and is included in one NDA.
The generic ingredient in ADVIL MULTI-SYMPTOM COLD is chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ADVIL MULTI-SYMPTOM COLD?
- What are the global sales for ADVIL MULTI-SYMPTOM COLD?
- What is Average Wholesale Price for ADVIL MULTI-SYMPTOM COLD?
Summary for ADVIL MULTI-SYMPTOM COLD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for ADVIL MULTI-SYMPTOM COLD |
| DailyMed Link: | ADVIL MULTI-SYMPTOM COLD at DailyMed |
US Patents and Regulatory Information for ADVIL MULTI-SYMPTOM COLD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | ADVIL MULTI-SYMPTOM COLD & FLU | chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride | TABLET;ORAL | 022113-002 | Apr 28, 2017 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
